A Phase II Clinical Study of Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer Failed of Standard Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Raltitrexed (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 29 Sep 2017 Status changed from not yet recruiting to recruiting.
- 03 Dec 2015 New trial record
- 02 Dec 2015 Planned initiation date changed from 1 Nov 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.